Zensar Technologies

ZENSARTECH (₹568.80) exhibits a strong daily uptrend, trading above all key moving averages and the Supertrend, supported by an ADX of 44.7. This bullish momentum is corroborated by a +6.1% upward gap on November 5 and a Morning Star pattern formation. However, the stock is positioned near the upper end of its 20-day (+90.5%) and 50-day (+92.0%) ranges, suggesting potential for short-term consolidation. While the weekly trend is also bullish, the monthly structure shows price below major moving averages despite a bullish Supertrend, indicating a longer-term recovery phase rather than a sustained bull market. Risk remains elevated with annualized volatility at +39.6% and a current drawdown of -38.2%. Immediate resistance lies at ₹573.22 (+0.78%), while support is found at ₹557.95 (-1.91%).

Zensar Technologies reported Q2FY27 results on 31 October 2026, showing a 4.4% year-on-year increase in net profit to ₹190.2 crore and an 11.5% revenue growth to ₹1,585.2 crore. Following these figures, brokerages issued rating updates on 3 November 2026; Zensar was downgraded to 'Add' with a target price of ₹614, contrasting with upgrades for peers like Delhivery. On 2 November 2026, analysts from HDFC Securities, Tradebulls Securities, and Anand Rathi Share and Stock Brokers cited technical breakouts and accumulation patterns for Zensar within broader market commentary.

Zensar Technologies Limited (NSE: ZENSARTECH) reported a material change in its capital structure on November 5, 2026, following the allotment of equity shares under an Employee Stock Option/Plan Scheme (ESOP). The Nomination and Remuneration Committee approved the issuance of 31,440 fully paid equity shares (₹2/- each) upon the exercise of previously granted options. This transaction increased the company's paid-up share capital from ₹455,486,664 to ₹455,549,544, raising the total number of paid-up shares from 227,743,332 to 227,774,772. The Board acted under authority granted during a prior meeting on January 19, 2016. As of the observation date of November 6, 2026, the stock traded at ₹568.80, reflecting a nominal increase from the previous close of ₹565.75.

Zensar Technologies Limited reported its financial results for the quarter ended September 30, 2026 (Q2FY27), on October 28, 2026. The Board approved unaudited standalone and consolidated results, noting a statutory impact from new Labour Codes as an exceptional item, with provisions of ₹235 Million (standalone) and ₹249 Million (consolidated). Additionally, the Board approved the merger of its wholly-owned subsidiary, M3BI India Private Limited, into Zensar, effective April 1, 2027, subject to regulatory approvals. On November 5, 2026, the company allotted 31,440 equity shares upon the exercise of Employee Stock Options, increasing paid-up share capital from ₹455,486,664 to ₹455,549,544.

Zensar Technologies demonstrates a strengthening operating trajectory in Q2 FY2026-27, with revenue from operations rising sequentially to ₹1,585 crore and net profit increasing to ₹190 crore. This follows a robust full-year performance where sales grew to ₹5,687 crore and net profit reached ₹775 crore for Mar 2026, supported by a 15% TTM compounded profit growth rate. Earnings quality remains high, evidenced by CFO/EBITDA conversion of 105% in Mar 2026 and strong ROCE of 23%. The balance sheet shows improved liquidity, with cash and equivalents rising to ₹391 crore and bank balances (excluding cash) jumping to ₹667 crore as of Sep 2026. While borrowings have declined steadily to ₹64 crore, working capital efficiency has tightened slightly, with the cash conversion cycle extending to 59 days in Mar 2026. Institutional ownership is shifting, with FIIs reducing their stake to 10.21%, while DIIs increased to 21.71%.

Zensar Technologies presents a conditional upside case anchored by improving operational momentum and technical structure, despite a bearish one-year price trend. In the September quarter (Q2FY27), the company delivered an 11.5% year-on-year revenue growth to ₹1,585.2 crore, accompanied by a 4.4% increase in net profit to ₹190.2 crore. This demonstrates top-line expansion capability within the mid-sized IT services segment.

Technically, the stock exhibits strong bullish signals across multiple timeframes as of November 6, 2026. The daily Supertrend is bullish with a Plus DI (39.79) significantly outweighing the Minus DI (8.83), indicating active buying pressure. Similarly, the weekly and monthly trends show bullish Supertrend directions. Short-term returns are positive, with the stock up +27.7% over the last month and +15.2% over the past 10 days, suggesting recent accumulation. However, this constructive setup exists against a backdrop of significant long-term underperformance, with the stock down -19.1% over the past year and currently trading at a -38.2% drawdown from its peak. The immediate condition for sustaining this momentum is a breakout above the nearest resistance level at ₹573.22.

Zensar Technologies presents a mixed operational and technical profile as of November 2026. While the company reported solid fundamental growth in the September quarter—with revenue rising 11.5% to ₹1,585.2 crore and net profit increasing 4.4% to ₹190.2 crore—market sentiment has turned cautious. Brokerages have downgraded the stock from previous ratings to 'Add' with a target price of ₹614, signaling limited near-term upside relative to current levels. Technically, the stock is trading at ₹568.8, well below its broker-implied target and facing immediate resistance just 0.78% higher at ₹573.22. The broader trend remains weak, evidenced by a year-to-date decline of -18.9% and a one-year return of -19.1%. Furthermore, the stock is currently in a significant drawdown of -38.2%, having experienced a maximum historical drawdown of -54.1%, indicating substantial volatility and downside risk for investors holding positions.